Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EMPAGLIFLOZIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | EMPAGLIFLOZIN |
| Key Genes/Proteins | AKT, AMPK, AMYLOID, BDNF |
| Related Diseases | ALZHEIMER'S DISEASE, APOPTOSIS, ATP, AUTOPHAGY, BLOOD-BRAIN BARRIER DISRUPTION |
graph TD
EMPAGLIFLOZIN[EMPAGLIFLOZIN]
EMPAGLIFLOZIN -->|activates| AMPK[AMPK]
EMPAGLIFLOZIN -->|activates| PARP1[PARP1]
EMPAGLIFLOZIN -.protects against.-> HYDROGEN_PEROXIDE[HYDROGEN PEROXIDE]
EMPAGLIFLOZIN -->|regulates| BDNF[BDNF]
EMPAGLIFLOZIN -.protects against.-> PARKIN[PARKIN]
EMPAGLIFLOZIN -->|treats| PARKINSON_S_DISEASE[PARKINSON'S DISEASE]
DEMENTIA[DEMENTIA] -.protects against.-> EMPAGLIFLOZIN
ATP[ATP] -->|activates| EMPAGLIFLOZIN| Target | Relation | Type | Str |
|---|---|---|---|
| AMPK | activates | protein | 0.80 |
| MEMANTINE | treats | drug | 0.65 |
| BLOOD-BRAIN BARRIER DISRUPTION | inhibits | phenotype | 0.65 |
| MICROGLIA | activates | cell_type | 0.65 |
| ISCHEMIA | protects_against | disease | 0.65 |
| ASTROCYTE | inhibits | cell_type | 0.65 |
| ASTROCYTE | activates | cell_type | 0.65 |
| NLRP3 INFLAMMASOME | activates | pathway | 0.65 |
| PARKINSON'S DISEASE | protects_against | disease | 0.65 |
| PARKINSON'S DISEASE | activates | disease | 0.65 |
| OXIDATIVE STRESS | activates | phenotype | 0.65 |
| OXIDATIVE STRESS | protects_against | phenotype | 0.65 |
| ISCHEMIA | inhibits | disease | 0.65 |
| MICROGLIAL ACTIVATION | inhibits | phenotype | 0.65 |
| NEUROINFLAMMATION | interacts_with | phenotype | 0.65 |
| NEUROINFLAMMATION | activates | phenotype | 0.65 |
| BDNF | inhibits | gene | 0.65 |
| BDNF | activates | gene | 0.65 |
| PARP1 | activates | gene | 0.65 |
| HYDROGEN PEROXIDE | protects_against | phenotype | 0.65 |
| PARKIN | protects_against | gene | 0.65 |
| PARKIN | activates | gene | 0.65 |
| HYDROGEN PEROXIDE | activates | phenotype | 0.65 |
| BDNF | regulates | gene | 0.65 |
| PARKINSON'S DISEASE | treats | disease | 0.65 |
| AMYLOID | associated_with | protein | 0.50 |
| APOPTOSIS | associated_with | phenotype | 0.50 |
| DEMENTIA | associated_with | disease | 0.50 |
| TAU | associated_with | protein | 0.50 |
| MEMANTINE | associated_with | drug | 0.45 |
| INFLAMMATION | associated_with | phenotype | 0.45 |
| AMPK | associated_with | gene | 0.45 |
| AUTOPHAGY | associated_with | phenotype | 0.45 |
| MICROGLIA | associated_with | cell_type | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| NEURON | associated_with | cell_type | 0.45 |
| ATP | associated_with | phenotype | 0.45 |
| ISCHEMIA | associated_with | disease | 0.45 |
| STROKE | associated_with | disease | 0.45 |
| NEURONS | associated_with | cell_type | 0.45 |
| WHITE MATTER | associated_with | brain_region | 0.45 |
| ASTROCYTE | associated_with | cell_type | 0.45 |
| NEUROGENESIS | associated_with | phenotype | 0.45 |
| DEPRESSION | associated_with | disease | 0.45 |
| CYTOKINES | associated_with | phenotype | 0.45 |
| TNF | associated_with | gene | 0.45 |
| IL6 | associated_with | gene | 0.45 |
| NLRP3 | associated_with | gene | 0.45 |
| PI3K | associated_with | gene | 0.45 |
| AKT | associated_with | gene | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ATP | activates | phenotype | 0.65 |
| DEMENTIA | protects_against | disease | 0.65 |
| DEMENTIA | inhibits | disease | 0.65 |
| TAU PHOSPHORYLATION | associated_with | phenotype | 0.50 |
| NEUROINFLAMMATION | associated_with | phenotype | 0.50 |
| OXIDATIVE STRESS | associated_with | phenotype | 0.50 |
| HYDROGEN PEROXIDE | associated_with | phenotype | 0.45 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.45 |
| MICROGLIAL ACTIVATION | associated_with | phenotype | 0.45 |
| NLRP3 INFLAMMASOME | associated_with | pathway | 0.45 |
| BLOOD-BRAIN BARRIER DISRUPTION | associated_with | phenotype | 0.45 |
| ENDOTHELIAL CELLS | associated_with | cell_type | 0.45 |
| PARKINSON'S DISEASE | associated_with | disease | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning EMPAGLIFLOZIN in their description or question text
No additional research found